While covalent binding can lead to toxicity, it is also harnessed in drug design to enhance the efficacy and selectivity of therapeutic agents. For example, some anticancer drugs are designed to form covalent bonds with specific proteins, ensuring prolonged and potent inhibition. However, the challenge lies in achieving this without undesirable off-target effects.
